Oncology
1 drug is in development for Chronic Myeloid Leukemia.
- Companies
- 1
- Clinical trials
- 21
Prepared research question
Which programs lead the Chronic Myeloid Leukemia pipeline—and what evidence could change the picture?
Traceable citations · Unknowns marked
Drug Pipeline by Phase
| Drug | Company |
|---|---|
| MGD024 | MACROGENICS INC (MGNX) |
About this indication
Chronic Myeloid Leukemia context
Also known as: Chronic Granulocytic Leukemia, Chronic Granulocytic Leukemias, Chronic Myelocytic Leukemia, Chronic Myelocytic Leukemias, Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemias, Chronic Myeloid Leukemias, Leukemia, Granulocytic, Chronic, Leukemia, Myelocytic, Chronic, Leukemia, Myelogenous, Chronic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myelogenous, Ph1 Positive, Leukemia, Myeloid, Chronic, Leukemia, Myeloid, Ph1 Positive, Leukemia, Myeloid, Philadelphia Positive, Leukemia, Ph1-Positive Myelogenous, Leukemia, Ph1-Positive Myeloid, Leukemia, Philadelphia-Positive Myeloid, Leukemias, Ph1-Positive Myelogenous, Leukemias, Ph1-Positive Myeloid, Leukemias, Philadelphia-Positive Myeloid
Prevalence
12.0 / 100K
Incidence
1.9 / 100K/yr
Frequently asked questions
How many drugs are in development for Chronic Myeloid Leukemia?
BioSniper tracks 1 drug in development for Chronic Myeloid Leukemia across 1 company.
How many clinical trials target Chronic Myeloid Leukemia?
There are 21 clinical trials targeting Chronic Myeloid Leukemia tracked by BioSniper.
What is the prevalence of Chronic Myeloid Leukemia?
The estimated prevalence of Chronic Myeloid Leukemia is approximately 12.0 per 100,000 population.